TriNetX
PrivateLast Round
Corporate Funding
Apr 2, 2026
Total Funding Raised
$268.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
TriNetX operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Corporate Funding round in April 2026.
TriNetX is a healthcare technology company that operates a global health research network to enhance clinical trial design and recruitment through the integration of EMR data and clinical documentation.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Healthcare Analytics, Business Intelligence
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TriNetX Comparables
Compare TriNetX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| nference | 86% | |
| OM1 | 84% | |
| Truveta | 82% |
For institutional investors. Book with your work email.
TriNetX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Apr 2, 2026 | ||||
| Private Equity | Sep 21, 2020 | ||||
| Series D | Mar 13, 2019 | ||||
| Series A | Jun 1, 2015 | ||||
| Series B | Jun 1, 2015 |
For institutional investors. Book with your work email.
TriNetX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series B, Series D |
| MPM Capital | Series B, Series D, Series A |
| ITOCHU Technology Ventures | Series D |
| The Carlyle Group | Private Equity |
| ITOCHU Technology Ventures | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 55% MoM.
- Apr 7, 2026
Acquired key assets from current partner Zetta Genomics.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 10, 2026
TriNetX, LLC launches NLP-extracted Facts from Clinical Notes, which provide confidence-scored, human-validated clinical data linked to structured EHR records, and makes them available in the TriNetX LIVE platform and downloadable datasets in Massachusetts on Nov 10th '26.
- launchesNov 10, 2026
TriNetX, LLC launches NLP-extracted Facts from Clinical Notes, which provides human-validated, confidence-scored clinical facts linked to structured EHR data, in its TriNetX LIVE platform and downloadable datasets in Massachusetts on Nov 10th '26.
For institutional investors. Book with your work email.
TriNetX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TriNetX's valuation, stock price, and market status.
Is TriNetX a public or private company?
TriNetX is a private company.
What is the current stock price of TriNetX?
TriNetX is a private company, so its shares have no public market price. Caplight tracks TriNetX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TriNetX worth (valuation)?
Valuation information for TriNetX is not publicly available.
Can I buy TriNetX stock?
TriNetX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TriNetX's last funding round?
TriNetX's most recent funding round was Corporate Funding on April 2, 2026.
Who are the main investors in TriNetX?
Key investors in TriNetX include MPM Capital, The Carlyle Group.
Will TriNetX IPO soon?
No public IPO plans have been announced for TriNetX.
How can I track TriNetX secondary market activity?
Caplight tracks bids, offers, and trades in TriNetX's shares on secondary markets.